Is Buclizine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Buclizine.

Is Buclizine approved by the US FDA?

Drugs@FDA lists 1 application product line for Buclizine, including BUCLADIN-S (Discontinued).

Active substance

Buclizine

SFDA 2
US FDA 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
LONGIFENE 1% SYRUP	1 %	Syrup · Oral use	1 Bottle	SAR 9.15	NCE · Prescription	U.C.B.	Withdrawn by MAH · Not Marketed
LONGIFENE 25 MG TAB	25 mg	Tablet · Oral use	25 Blister	SAR 7.70	NCE · Prescription	U.C.B.	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
BUCLADIN-S	50MG	tablet · oral	STUART PHARMS	Discontinued	8 Apr 1957

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.